1. Home
  2. VALN vs GBLI Comparison

VALN vs GBLI Comparison

Compare VALN & GBLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

HOLD

Current Price

$4.97

Market Cap

495.5M

Sector

Health Care

ML Signal

HOLD

Logo Global Indemnity Group LLC (DE)

GBLI

Global Indemnity Group LLC (DE)

HOLD

Current Price

$27.50

Market Cap

398.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALN
GBLI
Founded
2012
2016
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Property-Casualty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
495.5M
398.7M
IPO Year
2021
2010

Fundamental Metrics

Financial Performance
Metric
VALN
GBLI
Price
$4.97
$27.50
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$15.50
N/A
AVG Volume (30 Days)
21.6K
8.0K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
5.13%
EPS Growth
N/A
N/A
EPS
N/A
0.29
Revenue
N/A
$450,098,000.00
Revenue This Year
N/A
$14.23
Revenue Next Year
$93.87
$9.68
P/E Ratio
N/A
$94.82
Revenue Growth
N/A
2.02
52 Week Low
$4.75
$24.28
52 Week High
$12.25
$30.52

Technical Indicators

Market Signals
Indicator
VALN
GBLI
Relative Strength Index (RSI) 43.68 61.68
Support Level $4.75 $27.45
Resistance Level $5.52 $29.07
Average True Range (ATR) 0.13 0.62
MACD 0.03 0.14
Stochastic Oscillator 46.32 79.57

Price Performance

Historical Comparison
VALN
GBLI

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About GBLI Global Indemnity Group LLC (DE)

Global Indemnity Group LLC is a United States-based holding company with a diversified portfolio of property and casualty insurance-related entities. Along with its subsidiaries, the company operates in the following reportable segments: Agency and Insurance Services, Belmont Insurance Companies - Core (Belmont Core), and Belmont Insurance Companies - Non-Core (Belmont Non-Core). Maximum revenue is generated from the Belmont Core segment, which offers direct insurance and assumed reinsurance products in the E&S (Excess and Surplus) marketplace. The Agency and Insurance Services segment is focused on sourcing, underwriting, and servicing primary and assumed reinsurance business; and specialized insurance service businesses providing technology, AI-enabled marketplace, and claims services.

Share on Social Networks: